No abstract available
Keywords:
acquired progressive lymphangioma; benign lymphangioendothelioma; lymphatic malformation; mTOR inhibitor; vascular anomaly.
MeSH terms
-
Child
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lymphangioma*
-
Lymphatic Abnormalities* / diagnosis
-
Lymphatic Abnormalities* / drug therapy
-
Sirolimus / therapeutic use
Substances
-
Sirolimus
-
Immunosuppressive Agents